1 Min Read
March 8 (Reuters) - PDL Biopharma Inc:
* PDL BIOPHARMA ANNOUNCES FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS
* Q4 GAAP EARNINGS PER SHARE $0.15 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.